Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes

Journal of Diabetes and its Complications

Volumn 28, Issue 1, 2014, Pages 35-39

  Buraczynska, Monika ^a   Wacinski, Piotr ^a   Zukowski, Pawel ^a   Dragan, Michal ^a   Ksiazek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Gene polymorphism; Risk allele; Type 2 diabetes

Indexed keywords

CANNABINOID 1 RECEPTOR; GENOMIC DNA; GLUCOSE; HEMOGLOBIN A1C; CNR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPING TECHNIQUE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; AGED; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; GENETIC ASSOCIATION; GENETICS; GENOTYPE; MICROCIRCULATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CANNABINOID, CB1;

EID: 84891835841     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.08.005     Document Type: Article

References (35)

1. F. Barutta, A. Corbelli, R. Mastrocola, R. Gambino, V. diMarzo, and S. Pinach et al. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy Diabetes 59 2010 1046 1054
2. M. Benzinou, J.C. Chevre, K.J. Ward, C. Lecoeur, C. Dina, and S. Lobbens et al. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations Human Molecular Genetics 17 2008 1916 1921
3. J. Bienertova-Vascu, P. Bienert, Z. Dostalova, J. Chovanec, A. Vascu, and V. Vascu A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with pre-eclampsia in the Central European population European Journal of Obstetrics, Gynecology, and Reproductive Biology 155 2011 19 22
4. I. Cilensek, S. Mankoc, M. Globocnik Petrovic, and D. Petrovic GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy Disease Markers 32 2012 93 99
5. 1) gene with metabolic syndrome by ATPIII classification Diabetes/Metabolism: Research & Reviews 27 2011 506 511
6. J.M. de Miguel-Yanes, A.K. Manning, P. Shrader, J.B. Mc Ateer, A. Goel, and A. Hamsten et al. Variants at the cannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease Obesity 19 2011 2031 2037
7. A.B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.T. Tsai, R.B. Caldwell, and G.I. Liou Neuroprotective and blood-retinal barrier-preserving effects of cannabidol in experimental diabetes American Journal of Pathology 168 2006 235 244
8. A.B. El-Remessy, M. Rajesh, P. Mukhopadhyay, B. Horvath, V. Patel, and M.M. Al-Gayyar et al. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line Diabetologia 54 2011 1567 1578
9. P.W. Franks Gene - environment interactions in type 2 diabetes Current Diabetes Reports 11 2011 552 561
10. T.M. Frayling Genome-wide association studies provide new insights in type 2 diabetes aetiology Nature Reviews Genetics 8 2007 657 662
11. M. Globocnik Petrovic, B. Peterlin, M. Hawlina, and D. Petrovic Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in type 2 diabetes in Caucasians Journal of Diabetes and its Complications 19 2005 70 73
12. B. Horvath, P. Mukhopadhyay, G. Hasko, and P. Pacher The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications American Journal of Pathology 180 2012 432 442
13. 1 cannabinoid receptors and their associated proteins Current Medical Chemistry 17 2010 1382 1393
14. W.C. Hu, and P. Feng G1359 polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population Archives of Medical Research 41 2010 378 382
15. M. Imamura, and S. Maeda Genetics of type 2 diabetes: the GWAS era and future perspectives Endocrine Journal 58 2011 723 739
16. P. Janiak, B. Poirier, J.P. Bidouart, C. Cadrouvele, F. Pierre, and L. Gouraud et al. Blockade of cannabinoid CB1 receptor improves renal function, metabolic profile, and increased survival of obese Zucker rats Kidney International 72 2007 1345 1357
17. K.A. Jenkin, A.N. Verty, A.J. McAinch, and D.H. Hryciw Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathy The International Journal of Biochemistry & Cell Biology 44 2012 2028 2031
18. J.C. Lim, S.K. Lim, H.J. Han, and S.H. Park Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells Journal of Cellular Physiology 225 2010 654 663
19. S.K. Lim, M.J. Park, J.C. Lim, J.C. Kim, H.J. Han, and G.Y. Kim Hyperglycemia induces apoptosis via CB(1) activation through the decrease of FAAH1 in retina pigment epithelial cells Journal of Cellular Physiology 227 2012 569 577
20. R. Liu, and Y. Zhang G1359A polymorphism of the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population Clinical Laboratory 57 2011 689 693
21. J. Makuc, and D. Petrovic A review of oxidative stress related genes and new antioxidant therapy in diabetic nephropathy Cardiovascular & Hematological Agents in Medicinal Chemistry 9 2011 253 261
22. M. Marcos, I. Pastor, C. de la Calle, L. Barrio-Real, F.J. Laso, and R. Gonzalez-Sarmiento Cannabinoid receptor 1 gene is associated with alcohol dependence Alcoholism, Clinical and Experimental Research 36 2012 267 271
23. I. Matias, J.W. Wang, A.S. Mariello, A. Nieves, D.F. Woodward, and V. Di Marzo Changes in endocannabinoid and palmitoylethanclamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration Prostaglandins, Leukotrienes, and Essential Fatty Acids 75 2006 413 418
24. L.K. Miller, and L.A. Devi The highs and lows of cannabinoid receptor expression in disease: Mechanisms and their therapeutic implications Pharmacological Reviews 63 2011 461 470
25. K. Mohammedi, S. Maimaitiming, N. Emery, N. Bellili-Munoz, R. Roussel, and F. Fumeron et al. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects Molecular Genetics and Metabolism 104 2011 654 660
26. M. Murea, L. Ma, and B.I. Freedman Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications The Review of Diabetic Studies 9 2012 6 22
27. E.E. Nitzani, and F.K. Kavvoura Genetic risk factors for type 2 diabetes: Insights from the emerging genomic evidence Current Vascular Pharmacology 10 2012 147 155
28. P. Pacher, and S. Steffens The emerging role of the endocannabinoid system in cardiovascular disease Seminars in Immunopathology 31 2009 63 77
29. J.R. Petrie, E.R. Pearson, and C. Sutherland Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology Biochemical Pharmacology 81 2011 471 477
30. M. Rajesh, S. Batkai, M. Kechrid, P. Mukhopadhyay, W.S. Lee, and B. Horvath et al. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy Diabetes 61 2012 716 727
31. P. Russo, P. Strazzullo, F.P. Cappuccio, D.A. Tregouet, F. Lauria, and M. Loguercio et al. Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men Journal of Clinical Endocrinology and Metabolism 92 2007 2382 2386
32. S.W. Schwartz, M.A. Brantley Jr., and H.W. Flynn Jr. Genetics of diabetic retinopathy Current Diabetes Reviews 9 2013 86 92
33. M. Storr, D. Emmerdinger, J. Diegelmann, S. Pfennig, T. Ochsenkühn, and B. Göke et al. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease PLoS One 5 2010 e9453
34. R. Wang, W. Hu, and L. Qiang G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes Journal of Investigative Medicine 60 2012 44 48
35. P.W. Zhang, H. Ishiguro, T. Ohtsuki, J. Hess, E. Carillo, and D. Walther et al. Human cannabinoid receptor 1:5 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse Molecular Psychiatry 9 2004 916 931